Reversible suppression by nalidixic acid of anchorage-independent growth of mouse cells transformed by 3-methylcholanthrene or an activated c-Ha-ras gene.
Effects of nalidixic acid and its derivatives were investigated on mouse cells transformed by methylcholanthrene or an activated c-Ha-ras oncogene. Our findings were as follows. Nalidixic acid preferentially suppressed growth in soft agar of transformed Balb/3T3 mouse cells induced by methylcholanthrene. The suppressive effect of nalidixic acid on growth in soft agar was reversible. Nalidixic acid reversibly reduced saturation density of these transformed cells. Oxolinic acid and pipemidic acid, which are derivatives of nalidixic acid, were less effective than nalidixic acid in suppressing growth in soft agar. Nalidixic acid suppressed growth in soft agar of NIH/3T3 mouse cells transformed by an activated c-Ha-ras, without affecting the amount of ras p21 proteins as detected by an immunoblotting analysis using a monoclonal antibody. These results show that nalidixic acid reversibly suppressed the expression of transformed phenotypes that were already being expressed.
Kaneko
M
M
National Cancer Centre Research Institute, Biophysics Division, Tokyo, Japan.
Horikoshi
J
J
D000818:Animals; D002461:Cell Line, Transformed; D002999:Clone Cells / Q000187:drug effects; D008748:Methylcholanthrene; D051379:Mice; D008807:Mice, Inbred BALB C; D008938:Mitosis / Q000187:drug effects; D009268:Nalidixic Acid / Q000494:pharmacology*; D015689:Oncogene Protein p21(ras) / Q000378:metabolism; D009857:Oncogenes; D010093:Oxolinic Acid / Q000494:pharmacology; D010876:Pipemidic Acid / Q000494:pharmacology
D009268:Nalidixic Acid; D008748:Methylcholanthrene; D015689:Oncogene Protein p21(ras); D010093:Oxolinic Acid; D010876:Pipemidic Acid